Document Detail

Nifedipine for intractable hiccups.
MedLine Citation:
PMID:  2314596     Owner:  NLM     Status:  MEDLINE    
Seven patients with intractable hiccups were treated with a calcium channel blocker, nifedipine. A daily dose of 30 to 60 mg of this drug stopped hiccups in 4 patients and improved them in a 5th patient. In 2 patients hiccups recurred within 24 hours after stopping nifedipine. Nifedipine can be effective against intractable hiccups in some patients.
D C Lipps; B Jabbari; M H Mitchell; J D Daigh
Related Documents :
11273316 - Effect of enalapril therapy on ventilatory pulmonary function tests in hypertensive pat...
2970216 - Focal renal artery stenosis caused by fibromuscular dysplasia: treatment by percutaneou...
9988956 - Aggressive blood pressure lowering is safe, but benefit is still hard to prove.
11924716 - Discriminating factors for recurrent hypertension in patients with primary aldosteronis...
3455036 - Endoscopy in patients undergoing gastroplasty for morbid obesity.
21149096 - The gradient ac/a ratio: what's really normal?
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Neurology     Volume:  40     ISSN:  0028-3878     ISO Abbreviation:  Neurology     Publication Date:  1990 Mar 
Date Detail:
Created Date:  1990-04-17     Completed Date:  1990-04-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  531-2     Citation Subset:  AIM; IM    
Neurology Service, Walter Reed Army Medical Center, Washington, DC 20307-5001.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Hiccup / drug therapy*
Middle Aged
Nifedipine / administration & dosage,  therapeutic use*
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cerebrospinal fluid production is reduced in healthy aging.
Next Document:  White matter dementia in chronic toluene abuse.